Lexology November 11, 2025
Private equity’s investments in healthcare have often struggled to meet expectations. Top-line growth and attractive exit multiples are elusive in a sector weighed down by legacy systems, labor costs, and regulatory complexity. The urgent question facing investors, operating partners, and portfolio company leaders is: How can we reinvigorate returns and unlock enterprise value?
In this article, we will explore how AI is already making an impact in specific use cases in HealthTech and tech-enabled services.
The AI moment for HealthTech
Our data show a clear gap in HealthTech company performance, especially for the PE owned mature mid-tier ones: despite double-digit revenue growth in HealthTech (26.7%) over the past 3 years, EBITDA margins lag well behind other industry segments. For most...







